Fulcrum Therapeutics’ Post

View organization page for Fulcrum Therapeutics, graphic

11,151 followers

Curt Oltmans, our Chief Legal Officer, has been named Chair of the Rare Disease Company Coalition. We are proud and excited to see his leadership be a continued voice for rare disease communities. #WeAreRare #Leadership

Victor Schwartz

Partner at Shook, Hardy & Bacon L.L.P.

4mo

Continued success . Congratulations No much how much success. You are lways modest Curt Please stay in touch. VSCHWARTZ@SHB.COM Please stay in touch

Like
Reply
Alex Sapir

President & CEO, Fulcrum Therapeutics

5mo

Congrats Curt!

Congratulations, Curt. I know that you will do a great job in this important role.

Like
Reply
Amanda Malakoff, MPA

Government Affairs, BridgeBio

5mo

Curt Oltmans I am impressed by your leadership. RDCC is lucky to have you serving as chair this year!

Like
Reply
Elizabeth David

VP, Janssen Supply Chain Quality, Advanced Therapies | CHIEF Member (Cell & Gene Therapy)

5mo

Amazing to see you continuing to shine, Curt! ✨ Congratulations!

Like
Reply

Well done, Curt! They are so lucky to have you in this post

Like
Reply
Jason Ford

Managing Director at Denville Partners

5mo

That is great news. Congrats !!

Like
Reply

Congratulations my friend!

Like
Reply
Victor Schwartz

Partner at Shook, Hardy & Bacon L.L.P.

5mo

Best wishes Curt. Well deserved

Like
Reply
Dorothy Collins

Patient Marketer Expert |Pharma Accreditation Expert | Healthcare Education Expert

4mo

Congrats! 🍾🎉🎊🎈

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics